SCHEMBL24967082

SCHEMBL24967082

CCSC(SCC)C(=O)c1cc(F)nn1[C@H](C)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 11/20 0.48
▸ BRD2 P25440 1/20 0.39
▸ BRD3 Q15059 1/20 0.39
▸ BRDT Q58F21 1/20 0.39
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ GABRA1 P14867 2/20 0.36
▸ GABRB2 P47870 2/20 0.36
▸ CYP11B1 P15538 2/20 0.36
▸ CYP11B2 P19099 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ABCB11 O95342 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ FAAH O00519 1/20 0.34
▸ PDE2A O00408 1/20 0.34
▸ GPBAR1 Q8TDU6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24967297 0.83 BRD4 (0.46) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24966208 0.82 BRD4 (0.45) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24966158 0.82 BRD4 (0.53) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL29792065 0.81 BRD4 (0.51) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24966204 0.80 BRD4 (0.52) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24966147 0.80 BRD4 (0.45) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24966865 0.80 BRD4 (0.45) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24967300 0.80 BRD4 (0.47) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24966209 0.79 BRD4 (0.43) BRD4BRD2BRD3BRDTCYP1A2
SCHEMBL24966011 0.79 GABRA1 (0.56) BRD4CYP1A2CYP3A4GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CYP21A2, CYP11B1, CYP11B2 BRD4 2260/4885BRD2 3025/4885BRD3 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback